Insider Trading & Ownership - Neumann Mark

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Neumann Mark
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2025-04-02
Sale		 2025-04-02
5:41 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 52,811 $132 $6,971,052 21,876
(Direct)		 View
2024-08-16
Sale		 2024-08-20
6:03 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 18,714 $75.08 $1,405,047 29,700
(Direct)		 View
2024-03-07
Sale		 2024-03-11
8:31 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 20,477 $66.23 $1,356,110 37,045
(Direct)		 View
2024-02-26
Sale		 2024-02-27
7:58 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 7,907 $70.13 $554,491 29,700
(Direct)		 View
2024-02-02
Sale		 2024-02-05
6:07 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 11,860 $67.15 $796,367 29,700
(Direct)		 View
2023-11-06
Sale		 2023-11-08
5:31 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 42,393 $55.63 $2,358,152 29,700
(Direct)		 View
2023-08-07
Sale		 2023-08-09
6:05 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 55,300 $58.79 $3,251,087 45,339
(Direct)		 View
2023-03-28
Sale		 2023-03-30
5:08 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 15,604 $54.31 $847,380 45,339
(Direct)		 View
2023-03-10
Sale		 2023-03-13
7:35 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 12,308 $43.84 $539,599 75,633
(Direct)		 View
2023-03-01
Sale		 2023-03-03
7:03 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 7,241 $50.01 $362,122 49,199
(Direct)		 View
2023-02-24
Sale		 2023-02-27
8:03 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 4,046 $47.12 $190,648 64,347
(Direct)		 View
2023-02-21
Sale		 2023-02-22
8:05 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 3,898 $47.01 $183,246 52,580
(Direct)		 View
2022-04-08
Sale		 2022-04-08
6:56 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 86,348 $64.37 $5,558,051 45,339
(Direct)		 View
2022-02-24
Sale		 2022-02-25
7:08 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 7,906 $52.21 $412,810 61,152
(Direct)		 View
2022-02-22
Sale		 2022-02-23
7:07 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 11,139 $55.29 $615,827 56,478
(Direct)		 View
2022-01-10
Sale		 2022-01-11
8:06 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 20,948 $40.78 $854,255 45,339
(Direct)		 View
2021-10-18
Sale		 2021-10-19
4:26 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 13,448 $40.86 $549,551 45,339
(Direct)		 View
2021-02-19
Sale		 2021-02-22
8:07 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 5,184 $39.22 $203,308 67,617
(Direct)		 View
2021-01-11
Sale		 2021-01-12
7:06 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 9,684 $32.02 $310,082 60,332
(Direct)		 View
2020-10-16
Sale		 2020-10-16
4:04 pm		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 6,792 $26.8 $182,026 41,568
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2025-04-02
Option Award		 2025-04-02
5:41 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 21,876 $0 21,876
(Direct)		 View
2025-03-06
Exercise		 2025-03-10
6:01 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 20,478 $0 65,944
(Direct)		 View
2025-03-06
Tax Withholding		 2025-03-10
6:01 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 5,572 $131.19 65,944
(Direct)		 View
2025-03-10
Tax Withholding		 2025-03-10
6:01 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 3,116 $131.24 65,944
(Direct)		 View
2025-03-01
Exercise		 2025-03-04
6:01 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 8,742 $0 58,506
(Direct)		 View
2025-03-01
Tax Withholding		 2025-03-04
6:01 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 3,709 $128.2 58,506
(Direct)		 View
2025-02-03
Option Award		 2025-02-04
5:31 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 33,744 $0 58,715
(Direct)		 View
2025-01-31
Tax Withholding		 2025-02-04
5:31 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 4,729 $127 58,715
(Direct)		 View
2024-08-16
Exercise		 2024-08-20
6:03 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 18,714 $36.89 29,700
(Direct)		 View
2024-08-16
Exercise		 2024-08-20
6:03 pm		 N/A
2031-02-22		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 18,714 $0 29,700
(Direct)		 View
2024-03-10
Exercise		 2024-03-11
8:31 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 7,345 $0 37,045
(Direct)		 View
2024-03-06
Exercise		 2024-03-08
5:59 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 13,132 $0 69,098
(Direct)		 View
2024-03-01
Option Award		 2024-03-05
7:05 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 26,227 $0 26,227
(Direct)		 View
2024-02-23
Exercise		 2024-02-27
7:58 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 7,907 $0 29,700
(Direct)		 View
2024-02-01
Option Award		 2024-02-05
6:07 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 11,860 $0 29,700
(Direct)		 View
2023-11-06
Exercise		 2023-11-08
5:31 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 26,754 $23.94 29,700
(Direct)		 View
2023-11-06
Exercise		 2023-11-08
5:31 pm		 N/A
2030-02-17		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 26,754 $0 29,700
(Direct)		 View
2023-08-07
Exercise		 2023-08-09
6:05 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 55,300 $18.59 45,339
(Direct)		 View
2023-08-07
Exercise		 2023-08-09
6:05 pm		 N/A
2028-10-14		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 55,300 $0 45,339
(Direct)		 View
2023-03-09
Option Award		 2023-03-13
7:35 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 16,708 $0 75,633
(Direct)		 View
2023-03-10
Exercise		 2023-03-13
7:35 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 7,344 $0 75,633
(Direct)		 View
2023-03-06
Option Award		 2023-03-08
7:52 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 39,398 $0 39,398
(Direct)		 View
2023-02-23
Exercise		 2023-02-27
8:03 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 7,906 $0 64,347
(Direct)		 View
2023-02-18
Exercise		 2023-02-22
8:05 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 11,139 $0 52,580
(Direct)		 View
2022-04-08
Exercise		 2022-04-08
6:56 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 86,348 $12.73 45,339
(Direct)		 View
2022-04-08
Exercise		 2022-04-08
6:56 pm		 N/A
2029-01-07		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 86,348 $0 45,339
(Direct)		 View
2022-03-10
Option Award		 2022-03-14
4:13 pm		 N/A
2032-03-09		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 39,950 $0 39,950
(Direct)		 View
2022-02-23
Exercise		 2022-02-25
7:08 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 7,906 $0 61,152
(Direct)		 View
2022-02-18
Exercise		 2022-02-23
7:07 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 11,139 $0 56,478
(Direct)		 View
2022-01-08
Exercise		 2022-01-11
8:06 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 20,948 $0 45,339
(Direct)		 View
2021-10-15
Exercise		 2021-10-19
4:26 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 13,448 $0 45,339
(Direct)		 View
2021-02-23
Option Award		 2021-02-25
4:24 pm		 N/A
2031-02-22		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 42,433 $0 42,433
(Direct)		 View
2021-02-18
Exercise		 2021-02-22
8:07 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 11,139 $0 67,617
(Direct)		 View
2021-01-08
Exercise		 2021-01-12
7:06 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 20,948 $0 60,332
(Direct)		 View
2020-10-15
Exercise		 2020-10-16
4:04 pm		 N/A
N/A		 Intra-Cellular Therapies Inc. ITCI Neumann Mark
EVP, Chief Commercial Officer		 13,448 $0 41,568
(Direct)		 View